Assertio (ASRT)
(Delayed Data from NSDQ)
$1.52 USD
-0.10 (-6.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.52 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Assertio Holdings, Inc. [ASRT]
Reports for Purchase
Showing records 21 - 40 ( 116 total )
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Raise Estimates And Target To $10 (From $8) Following Strong 1Q:23 Results
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
1Q23 Recap - Strong Trends; Rolvedon Tracking Well
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
The Pending Acquisition Of SPPI Expands And Further Diversifies ASRT?s Product Portfolio
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Model EPS Decline In 2023 On Higher Share Count And Rebound In 2024, As ASRT Leverages A More Diversified Product Offering
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
2022 On A Strong Note And Issues Solid 2023 Guidance
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Ends 2022 On A Strong Note And Issues Solid 2023 Guidance
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
4Q22 Recap - Indocin Driving Upside; PT to $9.50
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Forecast Strong 4Q:22 Results Year-Over-Year As ASRT Benefits From Improved Top Line And Margin
Provider: Sidoti CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Forecast Strong 4Q:22 Results Year-Over-Year As ASRT Benefits From Improved Top Line And Margin
Provider: Sidoti CSR
Analyst: Research Department